Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2026-03-04 @ 12:44 AM
Study NCT ID:
NCT03032406
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-22
First Post:
2017-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-24
First Submit QC Date:
None
Study First Post Date:
2017-01-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-10-03
Results First Submit QC Date:
None
Results First Post Date:
2025-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-10
Last Update Post Date:
2025-07-22
Last Update Post Date Type:
ACTUAL